Document Detail

Potential role of granulocyte-macrophage colony stimulating factor in patients with HIV infection.
MedLine Citation:
PMID:  3071329     Owner:  NLM     Status:  MEDLINE    
Abnormalities in leukocyte number and function contribute to the high incidence of infection in patients with HIV infection. Leukopenia is a frequent occurrence in patients with AIDS and AIDS-related diseases and is a major dose limiting factor in the treatment of HIV infected individuals with antiviral compounds and chemotherapy. Granulocyte-macrophage colony stimulating factor (GM-CSF) is a hematopoietic hormone that stimulates the growth and differentiation of myeloid progenitor cells in vitro and enhances the function of mature monocytes and neutrophils. Studies on the effects of this agent in patients with AIDS, indicate that GM-CSF causes increased production of neutrophils, monocytes, and eosinophils in a dose dependent fashion. Leukocytes produced in response to GM-CSF function normally as judged by in vitro tests. The effects of GM-CSF on HIV replication and expression in vivo are uncertain. Studies of the use of GM-CSF alone and in combination with antiretroviral, antimicrobial, antineoplastic agents or other hematopoietins and cytokines will help define its ultimate clinical utility in patients with HIV infection.
R T Mitsuyasu; D W Golde
Related Documents :
12091849 - Effect of combination antiretroviral therapy on cerebrospinal fluid hiv rna, hiv resist...
8935749 - Correction of neutropenia following treatment with granulocyte colony-stimulating facto...
12364939 - Cerebral trypanosomiasis and aids.
192809 - Virological and serological studies of neurological complications of acute hemorrhagic ...
1905549 - Diagnostic usefulness of cerebrospinal fluid in multiple sclerosis.
7957269 - Antibodies to antigen a60 in cerebrospinal fluid from patients with tuberculous meningi...
15037699 - Neuropsychiatric impact of hepatitis c on advanced hiv.
20415569 - Interventions for hiv and hepatitis c virus infections in recreational drug users.
16364079 - Long-term evolution of serum and liver viral markers in patients treated for chronic he...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Behring Institute Mitteilungen     Volume:  -     ISSN:  0301-0457     ISO Abbreviation:  Behring Inst. Mitt.     Publication Date:  1988 Aug 
Date Detail:
Created Date:  1989-04-26     Completed Date:  1989-04-26     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0367532     Medline TA:  Behring Inst Mitt     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  139-44     Citation Subset:  IM; X    
Division of Hematology/Oncology, UCLA School of Medicine.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acquired Immunodeficiency Syndrome / drug therapy*
Colony-Stimulating Factors / therapeutic use*,  toxicity
Drug Evaluation
Granulocyte-Macrophage Colony-Stimulating Factor
Growth Substances / therapeutic use*,  toxicity
Leukocyte Count / drug effects
Recombinant Proteins / therapeutic use*,  toxicity
Grant Support
Reg. No./Substance:
0/Colony-Stimulating Factors; 0/Growth Substances; 0/Recombinant Proteins; 83869-56-1/Granulocyte-Macrophage Colony-Stimulating Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Phase I/II study with GM-CSF in patients with myelodysplastic syndromes.
Next Document:  Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) following autologous m...